Peptides · Peptide comparison
Human Chorionic Gonadotropin (HCG) vs Triptorelin
A powerful hormone that mimics luteinizing hormone (LH) to stimulate your body's natural testosterone production while keeping your fertility intact—like having your cake and eating it too for men on hormone therapy.
GnRH agonist that helps manage prostate cancer, endometriosis, and early puberty by controlling sex hormones
- Hormone Support
- Hormone Support
At a glance
Quick comparison
Efficacy
Benefit ratings
Fertility Preservation
Testicular Health
Hormone Balance
Hormone Regulation
Cancer Management
Endometriosis Relief
Technical data
Compound specifications
Human Chorionic Gonadotropin (HCG)
- Molecular formula
- C1105H1770N318O336S26 (approximate)
- Molecular weight
- 36,700 g/mol (approximately)
- Half-life
- 24-36 hours
- Bioavailability
- High when injected subcutaneously or intramuscularly
- CAS number
- 9002-61-3
Triptorelin
- Molecular formula
- C64H82N18O13
- Molecular weight
- 1311.4 g/mol
- Half-life
- 2-3 hours (free peptide); 2-4 weeks (depot pamoate formulations)
- Bioavailability
- ~100% (intramuscular/subcutaneous injection)
- CAS number
- 57773-63-4
Protocols
Dosing compared
Human Chorionic Gonadotropin (HCG)
Subcutaneous
- 500-1,500 IU2-3 times per week · Ongoing with TRTDocumented clinical practice for preserving testicular function/fertility in men on testosterone therapy; 1,500-2,000 IU 2-3x/week is used for hypogonadotropic hypogonadism [6]. The popular 500 IU 2-3x/week maintenance figure reflects real-world practice rather than the FDA label. In controlled dosing, 250 IU every other day held intratesticular testosterone within 7% of baseline and 500 IU raised it 26% above baseline during testosterone administration [7]; 500 IU every other day preserved semen parameters with no azoospermia in men on TRT [8].
Intramuscular
- 500-1,000 IU3 times weekly for 3 weeks, then 2 times weekly for 3 weeks · 6-week induction courseFDA-labeled regimen for male hypogonadotropic hypogonadism (Pregnyl) [7]. Intramuscular is the only labeled route.
- 4,000 IU then taper to 2,000 IU3 times weekly · 4,000 IU for 6-9 months, then 2,000 IU for 3 additional monthsHigher-dose FDA-labeled regimen for inducing spermatogenesis/testicular descent (Pregnyl) [7].
Triptorelin
Intramuscular injection
- 3.75 mgOnce every 4 weeks · Ongoing while indicatedFDA-labeled 1-month depot (Trelstar) for advanced prostate cancer; single IM injection into either buttock [5].
- 11.25 mgOnce every 12 weeks · Ongoing while indicatedFDA-labeled 3-month depot (Trelstar). Strengths are not additive; chosen by desired interval [5].
- 22.5 mgOnce every 24 weeks · Ongoing while indicatedFDA-labeled 6-month depot (Trelstar for prostate cancer; Triptodur 22.5 mg for central precocious puberty, ages 2+) [5][6].
Applications
Best suited for
Human Chorionic Gonadotropin (HCG)
- Fertility Preservation During TRT
- If you're on testosterone therapy but want to keep your swimmers swimming, HCG is your best friend. It keeps your testes active and producing sperm even when external testosterone would normally shut that down. Research shows it can maintain or restore spermatogenesis in about 80% of men [3][4][8].
- Preventing Testicular Atrophy
- Nobody wants their boys to shrink. When you take external testosterone, your brain stops signaling your testes to work—and they get smaller from disuse. HCG mimics the signal (LH) that keeps them active, maintaining their size and function [6][14].
- Hypogonadotropic Hypogonadism
- If your pituitary gland isn't sending the right signals to your testes (low LH), HCG can step in and do the job. It's been used for decades to treat this condition, helping men achieve normal testosterone levels and fertility [3][6][13].
- Post-Cycle Therapy (PCT)
- After using anabolic steroids, your natural hormone production is suppressed. HCG can help jumpstart your testes back into action, speeding up the recovery of your natural testosterone production. It's often used as part of a comprehensive PCT protocol [9][15].
Triptorelin
- Managing advanced prostate cancer when combined with other treatments
- Triptorelin is particularly well-suited for individuals focused on managing advanced prostate cancer when combined with other treatments. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
- Relieving severe endometriosis pain and symptoms
- Triptorelin is particularly well-suited for individuals focused on relieving severe endometriosis pain and symptoms. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
- Delaying puberty development in children with early sexual maturation
- Triptorelin is particularly well-suited for individuals focused on delaying puberty development in children with early sexual maturation. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Safety profile
Side effects
Human Chorionic Gonadotropin (HCG)
Common
- Injection site reactions
- Headache
- Water retention
Uncommon
- Gynecomastia
- Mood changes
- Acne
Serious
- Blood clots
Triptorelin
No side effects recorded.
Research status
Safety & evidence
Human Chorionic Gonadotropin (HCG)
- Evidence level
- Strong human trials (Phase 3 or FDA approved)
- FDA status
- FDA approved for other use
- Safety overview
- HCG has been used medically for over 80 years with a well-established safety profile. [10] When used appropriately for male hypogonadism or fertility preservation, side effects are generally mild and manageable. The most common issues relate to elevated estrogen from increased testosterone aromatization, which can be managed with aromatase inhibitors if needed. [6][18] Serious side effects are rare when HCG is used under medical supervision.
Contraindications
- Hormone-sensitive cancers (prostate, breast) [6][23]
- Precocious puberty in children [23]
- Known allergy to HCG or any component [6][23]
- Pregnancy (in therapeutic male contexts) [23]
- Untreated thyroid or adrenal disorders [6]
Triptorelin
- Evidence level
- Strong human trials (Phase 3 or FDA approved)
- FDA status
- FDA approved for this use
- Safety overview
- Triptorelin (GnRH agonist) has extensive FDA-approved safety data spanning decades for prostate cancer, endometriosis, and precocious puberty indications. Initial testosterone surge upon initiation ("flare reaction") can worsen prostate cancer or spinal cord compression symptoms, requiring careful patient monitoring in first 1-2 weeks and use of androgen antagonists in high-risk patients. Hypogonadal effects including hot flashes, sexual dysfunction, and bone loss develop predictably with chronic GnRH suppression; bone density monitoring is recommended in patients on therapy >6 months.
Contraindications
- Pregnancy (can affect fetal development)
- Undiagnosed vaginal bleeding
- Known hypersensitivity to GnRH agonists
- Severe untreated depression
- Active spinal cord compression in prostate cancer (requires urgent decompression)
Decision guide
Which is right for you?
Human Chorionic Gonadotropin (HCG)
Choose Human Chorionic Gonadotropin (HCG) if…
- Fertility preservation during TRT
- Maintaining testicular size and function
- Natural testosterone stimulation
- Post-cycle therapy recovery
Triptorelin
Choose Triptorelin if…
- Managing advanced prostate cancer when combined with other treatments
- Relieving severe endometriosis pain and symptoms
- Delaying puberty development in children with early sexual maturation